The main objective of the Cellus Biomedica is to contribute in the field of regenerative medicine through the constant development of disruptive, innovative, safe, effective and high-quality solutions, based on solid scientific evidence and optimization of clinical and laboratory processes that allow the sophistication of its offer of personalized cellular products. The company's mission is to be a platform in Europe and Latin America to develop products based on mesenchymal stem cells in accordance with the highest levels of quality and safety in order to bring cell therapy to the world. The products / services offered are aimed at reducing the deterioration of joints and soft tissues caused by traumatic injuries, diseases or symptoms of aging. In 2017, the Cellus Biomedica was awarded a Business R&D&I Portfolio Project entitled “Development of CELLUSPHERES®, an innovative cell therapy product for tissue regeneration based on mesenchymal stem cells (MSC) expanded adults, with export potential ”(Project 17PIDE-80689). In 2018, Cellus Biomedica was awarded a CORFO grant. The grant entitled “Development of an acellular prototype for tissue regeneration based on the secretome of e3D MSCs grown in a bioreactor, with export potential” involves the use of culture techniques in bioreactors for its CELLUSPHERES technology. In 2019, the Cellus Biomedica benefited from PROCHILE EXPORTA for the development of its Strategic Innovation Office (OIE), currently our office is established in Europe, in the León Technology Park, Spain. In 2020, the Cellus Biomedica together with Clínica Cellus received the CORFO Consolida y Expande instrument to introduce its therapies (CellusSRF+®) in the EU, highly regulated markets that use Spain as a gateway. Finally in 2021, Cellus Biomedica currently has a first international projects supported by the Institute for Business Competitiveness of the Junta de Castilla y León for the scaling of MSC
Company Details
- Founded
- -
- Address
- Parque Tecnológico De León, Julia Morros 1, Oficina 105 Edificio De Usos Comunes,spain
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.cellus.cl/
- HQ
- Armunia, León
- Competitors
- Oncología de Precisión en Chile - Anillo, Master en Biotecnología Biomédica, Biomedica Molecular Medicine, Grupo Cellus S.A., BIOmedica, Biocross S.L., Quality Labs, Clínica Cellus, Scientific Society for Biomedical Research // Sociedad Científica de Investigación Biomédica (SCIB), VALCARCE GESTION TRANSPORTE SA.
Cellus Biomédica Questions
Cellus Biomédica's website is https://www.cellus.cl/
Cellus Biomédica's LinkedIn profile is https://es.linkedin.com/company/cellus-biom%C3%A9dica
Cellus Biomédica's industry is
Biotechnology Research
Cellus Biomédica's top competitors are
Oncología De Precisión En Chile - Anillo,
Master En Biotecnología Biomédica,
Biomedica Molecular Medicine,
Grupo Cellus S.a.,
Biomedica,
Biocross S.l.,
Quality Labs,
Clínica Cellus,
Scientific Society For Biomedical Research // Sociedad Científica De Investigación Biomédica (Scib),
Valcarce Gestion Transporte Sa.
Cellus Biomédica's categories are Biotechnology Research
Cellus Biomédica's founding year is 2017
